Use of radioguided surgery with [111In]-pentetreotide in the management of an ACTH-secreting bronchial carcinoid causing ectopic Cushing’s syndrome
- 1 March 2005
- journal article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 28 (3) , 72-78
Abstract
Intraoperative [111In]-pentetreotide scintigraphy with a hand-held gamma detector probe has recently been proposed to increase the intraoperative detection rate of small neuroendocrine tumors and their metastases. We report a case of a 28-yr-old woman with ectopic Cushing’s syndrome due to an ACTH-secreting bronchial carcinoid, in whom the use of radioguided surgery improved disease management. At presentation, radiolabeled pentetreotide scintigraphy was the only procedure able to detect the ectopic source of ACTH. After radiologic confirmation, the patient underwent removal of a bronchial carcinoid, with disease persistence. After surgery, pentetreotide scintigraphy showed pathologic uptake in the mediastinum not previously detected at surgery and only subsequently confirmed by radiologic studies. Despite a second thoracic exploration, hormonal, scintigraphic, and radiological evidence of residual disease persisted. Radioguided surgery was then performed using a hand-held gamma probe 48 h after iv administration of a tracer dose of radiolabeled [111In-DTPA-D-Phe1]-pentetreotide, which permitted detection and removal of multiple residual mediastinal lymph node metastases. Clinical and radiologic cure, with no evidence of tracer uptake at pentetreotide scintigraphy, was subsequently observed. The use of an intraoperative gamma counter appears a promising procedure in the management of metastatic ACTH-secreting bronchial carcinoids.Keywords
This publication has 20 references indexed in Scilit:
- Management of Occult Adrenocorticotropin-Secreting Bronchial Carcinoids: Limits of Endocrine Testing and Imaging TechniquesThe Journal of Clinical Endocrinology & Metabolism, 2003
- Usefulness of Somatostatin Receptor Scintigraphy in Patients with Occult Ectopic Adrenocorticotropin SyndromeThe Journal of Clinical Endocrinology & Metabolism, 1999
- Lack of Utility of111In-Pentetreotide Scintigraphy in Localizing Ectopic ACTH Producing Tumors: Follow-Up of 18 PatientsThe Journal of Clinical Endocrinology & Metabolism, 1999
- Growth hormone and prolactin responses to corticotrophin‐releasing‐hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?Clinical Endocrinology, 1998
- Bronchopulmonary carcinoid tumors associated with cushing's syndrome: A more aggressive variant of typical carcinoidThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Carcinoid tumors of the lung: Immuno- and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgicallyJournal of Surgical Oncology, 1996
- Petrosal Sinus Sampling with and without Corticotropin-Releasing Hormone for the Differential Diagnosis of Cushing's SyndromeNew England Journal of Medicine, 1991
- Management of the ectopic ACTH syndrome due to thoracic carcinoidsThe Annals of Thoracic Surgery, 1990
- Bronchial carcinoids: A review of 60 patientsThe Annals of Thoracic Surgery, 1989
- DIAGNOSIS AND MANAGEMENT OF ACTH‐DEPENDENT CUSHING'S SYNDROME: COMPARISON OF THE FEATURES IN ECTOPIC AND PITUITARY ACTH PRODUCTIONClinical Endocrinology, 1986